- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07796087
Three Distraction Techniques for Pain and Anxiety in Children During Allergy Skin Prick Testing
26. August 2026 aktualisiert von: Leyla Erdim, Istanbul University
The Effect of Three Different Distraction Techniques on Anxiety and Pain Levels in Children During Allergy Skin Prick Testing: A Randomized Controlled Trial
This randomized controlled trial compared three distraction techniques-animated cartoons, DistrACTION® Cards, and interactive video games-with standard care for reducing procedural pain and anxiety in children aged 6-10 years undergoing allergy skin prick testing.
A total of 161 children were randomly assigned to four groups.
Pain was rated by the child, a parent, and the researcher with the Wong-Baker FACES Pain Rating Scale during and after the procedure, and anxiety was rated by the parent and the researcher with the Children's Fear Scale before, during, and after the procedure.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Detaillierte Beschreibung
This single-center, four-arm, parallel-group randomized controlled trial was conducted in the pediatric allergy outpatient clinic of a training and research hospital in Istanbul, Turkey, between November 2019 and January 2020.
Children aged 6-10 years referred for allergy skin prick testing were randomly allocated by computer-generated assignment to a cartoon group (n = 40), a DistrACTION® Cards group (n = 40), a video game group (n = 40), or a standard-care control group (n = 41).
All tests were performed by the same pediatric nurse under identical conditions.
Between-group differences were tested with one-way ANOVA and change over time with two-way repeated-measures ANOVA.
Studientyp
Interventionell
Einschreibung (Tatsächlich)
161
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
-
Istanbul, Türkei (türkiye)
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Kind
Akzeptiert gesunde Freiwillige
Nein
Beschreibung
Inclusion Criteria:
- Aged 6-10 years
- Referred for allergy skin prick testing
- Consent of both child and parent
- No analgesic use in the previous six hours
- Able to understand the Wong-Baker FACES Pain Rating Scale and answer the card questions
Exclusion Criteria:
- Neurodevelopmental conditions (diagnosis of autism or intellectual disability)
- Chronic mental, cognitive, or visual problems
- Cognitive, visual, or hearing impairment preventing scale use
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Cartoon group (CG)
Children watched a self-selected, age-appropriate animated cartoon on a tablet computer during the skin prick test.
|
Children watched a self-selected, age-appropriate animated cartoon on a tablet computer during the skin prick test.
|
|
Experimental: DistrACTION® Cards group (DC)
Children viewed DistrACTION® Cards and answered goal-directed visual-search questions asked by the researcher during the skin prick test.
|
Children viewed DistrACTION® Cards and answered goal-directed visual-search questions asked by the researcher during the skin prick test.
|
|
Experimental: Video game group (VG)
Children played a self-selected interactive video game on a tablet with the non-tested arm during the skin prick test.
|
Children played a self-selected interactive video game on a tablet with the non-tested arm during the skin prick test.
|
|
Kein Eingriff: Control group (C)
Children received the clinic's standard protocol; the nurse explained and performed the test, and no additional distraction was provided.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Child-reported procedural pain
Zeitfenster: During the skin prick test, a procedure lasting approximately 3 minutes
|
Pain self-reported by the child on the Wong-Baker FACES Pain Rating Scale (0 = no pain to 10 = worst possible pain; higher scores indicate more pain).
|
During the skin prick test, a procedure lasting approximately 3 minutes
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Child-reported pain after the procedure
Zeitfenster: Immediately after the skin prick test, up to 15 minutes after the procedure
|
Pain self-reported by the child on the Wong-Baker FACES Pain Rating Scale (0 = no pain to 10 = worst possible pain; higher scores indicate more pain).
|
Immediately after the skin prick test, up to 15 minutes after the procedure
|
|
Parent-reported pain
Zeitfenster: During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
Pain reported by the parent on the Wong-Baker FACES Pain Rating Scale (0 = no pain to 10 = worst possible pain; higher scores indicate more pain).
|
During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
|
Researcher-reported pain
Zeitfenster: During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
Pain reported by the researcher on the Wong-Baker FACES Pain Rating Scale (0 = no pain to 10 = worst possible pain; higher scores indicate more pain).
|
During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
|
Parent-reported anxiety
Zeitfenster: Approximately 10 minutes before the skin prick test, during the test (approximately 3 minutes), and immediately after the procedure (up to 15 minutes)
|
Anxiety reported by the parent using the Children's Fear Scale (0 = no anxiety to 4 = severe anxiety; higher scores indicate higher anxiety).
|
Approximately 10 minutes before the skin prick test, during the test (approximately 3 minutes), and immediately after the procedure (up to 15 minutes)
|
|
Researcher-reported anxiety
Zeitfenster: Approximately 10 minutes before the skin prick test, during the test (approximately 3 minutes), and immediately after the procedure (up to 15 minutes)
|
Anxiety reported by the researcher using the Children's Fear Scale (0 = no anxiety to 4 = severe anxiety; higher scores indicate higher anxiety).
|
Approximately 10 minutes before the skin prick test, during the test (approximately 3 minutes), and immediately after the procedure (up to 15 minutes)
|
|
Interrater agreement
Zeitfenster: During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
Intraclass correlation coefficient between child, parent, and researcher ratings.
|
During the skin prick test (approximately 3 minutes) and immediately after the procedure (up to 15 minutes)
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Ermittler
- Hauptermittler: Leyla Erdim, Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
7. November 2019
Primärer Abschluss (Tatsächlich)
12. Januar 2020
Studienabschluss (Tatsächlich)
21. Januar 2020
Studienanmeldedaten
Zuerst eingereicht
24. August 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
26. August 2026
Zuerst gepostet (Tatsächlich)
31. August 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
31. August 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
26. August 2026
Zuletzt verifiziert
1. August 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2019-19-01
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Beschreibung des IPD-Plans
Individual participant data will not be shared.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .